Abba's Aces : I recently closed my position in Rite Aid Corporation (NYSE: RAD ) from my growth portfolio because I felt that ..... down 5.67% on my position. I sold my shares in Rite Aid because I had a great gain in a short Complete
By Leonard Yaffe : Historically, wholesale generic drug prices have declined rapidly, as more companies entered the market. However, several factors have occurred in the past few years that have led to dramatic price increases on a few select products. These include industry consolidation, ...
(Adds management comments, details on performance, updates shares)
are showing some weakness early after results from Rite Aid (NYSE: RAD ) take a hit from generic drug introductions. Walgreen ..... premarket, while CVS is tilting 0.6% south . Rite Aid ( RAD ) is in a dive, now down 13.4% . Post your comment
Sept 18 (Reuters) - Rite Aid Corp, the third largest U.S. drugstore chain, cut its full-year profit forecast for the second time this year as lower margins from its pharmacy business continue to eat into earnings.
Rite Aid (NYSE: RAD ) cuts its outlook on FY15 EPS to a range of $0.22-$0.33 vs ..... Same store sales are expected to rise 3% to 4% for the fiscal year. RAD -8.4% premarket Post your comment!
Rite Aid (NYSE: RAD ) reports same-store sales rose 4.1% in FQ2. The front-end comp rose 1.1%, while pharmacy sales jumped 5.6%. Prescription
Rite Aid (NYSE: RAD ): Q2 EPS of $0.13 beats by $0.07 . Revenue of $6.52B (+3.8% Y/Y) beats by $40M . Press Release Post your comment!
investors who have a stake in Rite Aid (NYSE: RAD ) don't seem terribly optimistic ..... should investors stay away from Rite Aid and opt for a rival like CVS Health ..... For the quarter, analysts expect Rite Aid to report revenue of $6.48 billion
fragmented markets--comprise the bulk of U.S. cigarette sales. Even if other pharmacies such as Walgreen WAG and Rite Aid RAD were to follow suit, tobacco should remain widely available for adults to purchase. Consumer staples ETFs' underlying